Clinical Trials Logo

Vitreomacular Adhesion clinical trials

View clinical trials related to Vitreomacular Adhesion.

Filter by:
  • None
  • Page 1

NCT ID: NCT02322229 Completed - Clinical trials for Vitreomacular Traction

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Start date: May 26, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA™®) over a 6-month period.

NCT ID: NCT02160340 Completed - Clinical trials for Vitreomacular Adhesion

Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older

VAST
Start date: May 2014
Phase:
Study type: Observational

The purpose of this study is to evaluate the prevalence of vitreomacular adhesion (VMA) in patients 40 years and older using Spectral Domain Optical Coherence Tomography.

NCT ID: NCT02035748 Completed - Clinical trials for Vitreomacular Traction

Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Start date: April 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to observe the anatomical and functional outcomes of ocriplasmin (JETREA®) over a 6-month follow-up period.

NCT ID: NCT02001701 Withdrawn - Clinical trials for Vitreomacular Adhesion

Intravitreal Gas for Vitreomacular Adhesion

RELEASE
Start date: November 2013
Phase: N/A
Study type: Interventional

Vitreomacular adhesion causes symptoms of blurry vision, distortion, and double vision. It is due to an abnormal separation of the vitreous gel from the surface of the retina and macula. The current, gold-standard treatment for this condition involves surgery performed in the operating room that involves risk such as bleeding, infection, cataract, and retinal detachment. It has been previously shown that a less invasive intravitreal injection of a gas bubble performed in the office may also treat vitreomacular adhesion with less risk than surgery. The purpose of this study is to determine the effect of an office-based injection of an intravitreal gas bubble as a treatment for symptomatic vitreomacular adhesion.

NCT ID: NCT01966328 Active, not recruiting - Clinical trials for Vitreomacular Traction

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

Start date: October 2013
Phase: Phase 1
Study type: Interventional

This research is studying the effect that Resolvine injection will have on patients with vitreomacular adhesion.

NCT ID: NCT00798317 Completed - Clinical trials for Vitreomacular Adhesion

Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

Start date: December 2008
Phase: Phase 3
Study type: Interventional

This trial will evaluate the safety and efficacy of microplasmin, administered as an intravitreal injection, in subjects with focal vitreomacular adhesion. In previously performed clinical trials, some patients treated with intravitreal microplasmin have had resolution of their underlying condition, including macular hole closure, without need for vitrectomy. This clinical trial is justified because the sponsor believes the potential benefits outweigh the potential risks.

NCT ID: NCT00781859 Completed - Clinical trials for Vitreomacular Adhesion

Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

Start date: December 2008
Phase: Phase 3
Study type: Interventional

The objective of this trial is to evaluate the safety and efficacy of intravitreal microplasmin 125µg dose in subjects wiht focal vitreomacular adhesion.